Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 1, 2015, Pages 55-59

  Eapen, Mary ^a   Logan, Brent R ^a   Appelbaum, Fredrick R ^b   Antin, Joseph H ^c   Anasetti, Claudio ^d   Couriel, Daniel R ^e   Chen, Junfang ^a   Maziarz, Richard T ^f   McCarthy, Philip L ^g   Nakamura, Ryotaro ^h   Ratanatharathorn, Voravit ^i,j   Vij, Ravi ^k   Champlin, Richard E ^l  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b USA   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

^h Blood and Marrow Transplant Program Department of Medicine Roswell Park Cancer Institute ^*  (United States)

ⁱ WAYNE STATE UNIVERSITY   (United States)

^j JP McCarthy Cord Stem Cell Bank   (United States)

^k WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

more..

Author keywords

Chronic graft versus host disease; Leukemia; Mortality

Indexed keywords

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; BLOOD DONOR; CANCER PATIENT; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ADOLESCENT; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; COMPARATIVE STUDY; GRAFT VS HOST DISEASE; IMMUNOLOGY; LEUKEMIA, BIPHENOTYPIC, ACUTE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PATHOLOGY; SURVIVAL ANALYSIS; TIME FACTOR; TRANSPLANTATION CONDITIONING; UNRELATED DONORS;

CALCINEURIN INHIBITOR; MYELOABLATIVE AGENT;

ADOLESCENT; ADULT; AGED; BONE MARROW TRANSPLANTATION; CALCINEURIN INHIBITORS; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA, BIPHENOTYPIC, ACUTE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; MYELODYSPLASTIC SYNDROMES; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; UNRELATED DONORS;

EID: 84927166028     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.09.006     Document Type: Article

References (12)

1. Anasetti C., Logan B.R., Lee S.J., et al. Peripheral blood stem cells versus bonemarrow from unrelated donors. NEngl J Med 2012, 367:1487-1496.
2. Schmitz N., Eapen M., Horowitz M.M., et al. Long-term outcome of patients given transplants of mobilized blood or marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 2006, 108:4288-4290.
3. Friedrichs B., Tichelli A., Bacigalupo A., et al. Long-term outcomes and late effects in patients transplanted with mobilized blood or bone marrow: a randomised trial. Lancet Oncol 2010, 11:331-338.
4. Bacigalupo A., Ballen K., Rizzo D., et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009, 15:1628-1633.
5. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host disease syndrome in man: a long-term clinicopathophysiologic study 20 Seattle patient. Am J Med 1980, 69:204-217.
6. Lin D.Y. Non-parametric inference for cumulative incidence function in competing risks. Stat Med 1997, 16:901-910.
7. Cox D.R. Regression models and life tables. Stat Soc B 1972, 4:187-200.
8. Flowers M.E., Parker P.M., Johnston L.J., et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 2002, 100:415-419.
9. Bacigalupo A., Lamperelli T., Barisione G., et al. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant 2006, 12:560-565.
10. Finke J., Bethge W.A., Schmoor C., et al. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in hematopoietic cell transplantation from matched unrelated donors: a randomized, open label, multicenter phase 3 trial. Lancet Oncol 2009, 10:855-864.
11. Socie G., Schmoor C., Bethge W.A., et al. Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. Blood 2011, 117:6375-6382.
12. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. JClin Oncol 2005, 23:5074-5087. Stem Cell Trialists Collaborative Group.